featured
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JACC: Cardiovascular Interventions
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy: A Meta-Analysis
JACC Cardiovasc Interv 2021 Mar 10;[EPub Ahead of Print], NL Pereira, C Rihal, R Lennon, G Marcus, S Shrivastava, MR Bell, D So, N Geller, SG Goodman, A Hasan, A Lerman, Y Rosenberg, K Bailey, MH Murad, ME FarkouhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.